← Back to Search

Potassium Citrate + Crystal Light for Kidney Stones

N/A
Recruiting
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Men and women between age 18-80 years
Completed Litholink Collection with blood work with results
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7 of week 5
Awards & highlights

Study Summary

This trial examines whether crystal light, potassium citrate, or both can help reduce urinary stone risk factors in patients with a history of stones and low pH.

Who is the study for?
This trial is for men and women aged 18-80 with a history of kidney stones and low urine citrate or pH levels. Participants must be able to follow the study plan, collect their urine for testing, sign consent forms, have normal blood work results, and not have severe hypocitraturia or other specific health issues.Check my eligibility
What is being tested?
The study aims to understand how potassium citrate alone, Crystal Light lemonade alone, or both combined affect factors in the urine that contribute to kidney stone formation in people who've had stones before and have low urinary citrate/pH.See study design
What are the potential side effects?
Possible side effects may include gastrointestinal discomfort due to potassium citrate or reactions related to ingredients in Crystal Light. However, specifics on side effects are not provided; participants should discuss potential risks with the research team.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 80 years old.
Select...
I have completed a Litholink test with blood work results available.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7 of week 5
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 7 of week 5 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
urine citrate levels

Trial Design

3Treatment groups
Active Control
Group I: Potassium citrateActive Control1 Intervention
Group II: Crystal lightActive Control1 Intervention
Group III: Crystal light + potassium citrateActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,579 Previous Clinical Trials
916,775 Total Patients Enrolled
3 Trials studying Kidney Stones
324 Patients Enrolled for Kidney Stones

Media Library

Crystal Light Clinical Trial Eligibility Overview. Trial Name: NCT05389995 — N/A
Kidney Stones Research Study Groups: Potassium citrate, Crystal light, Crystal light + potassium citrate
Kidney Stones Clinical Trial 2023: Crystal Light Highlights & Side Effects. Trial Name: NCT05389995 — N/A
Crystal Light 2023 Treatment Timeline for Medical Study. Trial Name: NCT05389995 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for participants in this experiment?

"As per the information on clinicaltrials.gov, this study is not currently recruiting participants; however, it was first listed on August 1st 2022 and last edited July 1st 2022. While patient recruitment has ceased for this trial at present, there are 88 other trials actively seeking enrolment."

Answered by AI

Does my profile qualify me to be part of this research project?

"This medical trial is hoping to enrol 10 individuals who have been diagnosed with kidney stones, aged between 18 and 80. In order to participate, they must be content with following the experimental protocol, complete 24-hour urine collections (three total) and sign an informed consent form. Additionally, results from a Litholink Collection test should demonstrate hypocitraturia OR aciduria (with men having < 450 mg/day of citrate in their system and women 550 mg/day). The pH balance of their urine needs to remain below 5.6 as well as normal levels for potassium, BUN creatinine eGFR hemoglobin"

Answered by AI

Does this study permit individuals aged 40 or more to take part?

"Participants of this clinical trial must be over the age of majority and no older than 80 years."

Answered by AI
~4 spots leftby Mar 2025